Document is current
Any future updates will be listed below
-
Authors
Liu, Yangjun http://orcid.org/0000-0002-3540-5361
Lichtenstein, Paul http://orcid.org/0000-0003-3037-5287
Kotov, Roman
Larsson, Henrik http://orcid.org/0000-0002-6851-3297
D’Onofrio, Brian M.
Pettersson, Erik
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2017-01358)
- License Information
-
More Information
Article History
Received: 24 August 2023
Revised: 31 March 2024
Accepted: 3 April 2024
First Online: 10 April 2024
Competing interests
: HL reports receiving grants from Shire Pharmaceuticals, personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB, and sponsorship for a conference on attention-deficit/hyperactivity disorder from Shire/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. HL is editor-in-chief of JCPP Advances. The other authors declare no competing interests.
